Source: Annual Congress 2007 - Pulmonary vascular involvement in smoking and respiratory diseases
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Popova, E. Kogan, A. Ponomarev, I. Popova (Moscow, Russian Federation). Angiogenesis and coagulation in the development of pulmonary hypertension in sarcoidosis. Eur Respir J 2007; 30: Suppl. 51, 3577

Member's Comments

No comment yet.

Related content which might interest you: Angiogenesis and coagulation in the development of pulmonary hypertension in idiopathic interstitial pneumonias (IIP) Source: Eur Respir J 2005; 26: Suppl. 49, 540s Year: 2005 Clinical evaluation of angiogenesis and coagulation in pulmonary sarcoidosis Source: Annual Congress 2011 - Cell biology of lung disease Year: 2011 Angiogenesis in idiopathic pulmonary fibrosis Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis Year: 2020 Crucial role of thrombin-activated fibrinolysis inhibitor in the pathogenesis of chronic thromboembolic pulmonary hypertension Source: International Congress 2015 – Pulmonary circulation: the story of fresh and old clots Year: 2015 The Role of Inflammation in promoting pulmonary hypertension in idiopatchi and connective tissue disease-associated PAH Source: Research Seminar 2008 - The Pulmonary Circulation: Scleroderma-Related Pulmonary Arterial Hypertension Year: 2008 Angiogenesis in experimental pulmonary fibrosis Source: Annual Congress 2009 - A wide spectrum of idiopathic pulmonary fibrosis Year: 2009 Pulmonary hypertension in sickle cell disease Source: Annual Congress 2007 - ACCP1 - Pulmonary hypertension in sickle cell disease Year: 2007 Endothelial NO and its pathophysiologic regulation Source: Annual Congress 2007 - Role of the endothelium in pulmonary function and disease Year: 2007 Updates in pulmonary hypertension and other pulmonary vascular diseases Source: Breathe, 15 (3) 241; 10.1183/20734735.0187-2019 Year: 2019 Angiogenesis in chronic thromboembolic pulmonary hypertension (CTEPH) Source: Annual Congress 2012 - Pulmonary circulation: acute and chronic pulmonary embolism Year: 2012 Pulmonary arterial hypertension in scleroderma – manifestation of systemic endothelial dysfunction Source: Eur Respir J 2006; 28: Suppl. 50, 548s Year: 2006 Pulmonary hypertension: pathophysiology and diagnosis Source: Annual Congress 2007 - PG19 - Pulmonary vascular disorders: diagnosis and treatment Year: 2007 Contribution of inflammation and impaired angiogenesis to the pathobiology of chronic thromboembolic pulmonary hypertension Source: Eur Respir J 2015; 46: 431-443 Year: 2015 Endothelial and platelet dysfunction in pulmonary hypertension due to sarcoidosis Source: Annual Congress 2008 - Pulmonary vascular biology Year: 2008 Evidence of lymphangiogenesis in pulmonary hypertension Source: Annual Congress 2010 - Pathobiology of pulmonary hypertension Year: 2010 Microvascular disease in chronic thromboembolic pulmonary hypertension: a role for pulmonary veins and systemic vasculature Source: Eur Respir J 2014; 44: 1275-1288 Year: 2014 Pulmonary lymphoid neogenesis in idiopathic pulmonary arterial hypertension Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms Year: 2012 First histopathological evidence of irreversible pulmonary vascular disease in dasatinib-induced pulmonary arterial hypertension Source: Eur Respir J, 51 (3) 1701694; 10.1183/13993003.01694-2017 Year: 2018 Immune and inflammatory cell involvement in the pathology of idiopathic pulmonary arterial hypertension Source: Annual Congress 2013 –Pulmonary circulation: basic science Year: 2013 Chronic thromboembolic pulmonary hypertension: role of medical therapy Source: Eur Respir J 2013; 41: 985-990 Year: 2013